In the News: 04/03

New Arthritis Drug Breaks The Marketing Mold-Its Free Abbot Laboratories, makers of the rheumatoid arthritis drug Humira, announced in January that it will provide its recently approved drug free to Medicare patients without drug coverage-at least until the government agrees to pay for it. The move, according to an article by reporter Bruce Japsen in the Chicago Tribune, is part altruism and part marketing because the companys drug is competing with a rival-Remicade-that has Medicare coverage.…
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access